Favorable outcome of immunotherapy use in metastatic HR+/HER2- breast cancer: a population-based cohort study
免疫疗法在转移性HR+/HER2-乳腺癌中的良好疗效:一项基于人群的队列研究
期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000003556
Zhong, Guansheng; Hu, Jingjing; Wei, Luxin; Wei, Bajin; Cui, Haidong; Lou, Weiyang; Ma, Jinfei; Shao, Wanting; Zhang, Lifeng; Dai, Zhijun